Baird raised the firm’s price target on Genpact (G) to $48 from $44 and keeps a Neutral rating on the shares. The firm said Q3 results were good as revenue/margins/EPS were above Street and guidance was raised;Baird views the risk/reward as mildly positive.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.